Abstracto
Blend of ophthalmic molecular pathology and oncology in retinoblastoma
Adler Sikorski*
In 2006, the American association of ophthalmic pathologists perceived the advantages of coupling ophthalmic pathology with a clinical forte; in particular, visual oncology since there is such a lot of cross over between the two and various ophthalmologists are prepared in both.
Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.